Alida Biosciences’ EpiPlex platform uses robust assay controls and specialized bioinformatics to detect RNA modification, genomic coordinates, and relative quantity.

This article was originally published by The Conversation. After the Sept. 10, 2025, assassination of conservative political activist Charlie Kirk, President Donald Trump claimed that radical leftist ...

A monthslong NBC News data investigation finds that much of the U.S. doesn't have the protection needed to stop the spread of deadly diseases. St. Louis is a window into the problem communities face ...

At the “Make with Notion” event on Thursday, the company announced the launch of its first AI agent. The agent will draw on all of a user’s notion pages and database as context, automatically ...

Blake has over a decade of experience writing for the web, with a focus on mobile phones, where he covered the smartphone boom of the 2010s and the broader tech scene. When he's not in front of a ...

President Donald Trump is threatening to send the military to Chicago, calling the city a "killing field" and claiming violent crime is out of control. But data from the Chicago Police Department and ...

As millions of Americans gather Monday to celebrate Labor Day, federal data shows how President Trump's immigration policies are reshaping the U.S. workforce. The number of immigrant workers in the ...

New types of AI coding assistants promise to let anyone build software by typing commands in plain English. But when these tools generate incorrect internal representations of what's happening on your ...

AI data centers are consuming energy at roughly four times the rate that more electricity is being added to grids, setting the stage for fundamental shifts in where power is generated, where AI data ...

The Trump administration has expanded Palantir’s work with the government, spreading the company’s technology — which could easily merge data on Americans — throughout agencies. Alex Karp, a ...

Optimizing an NGS low-pass–based method to detect genomic instability as a PARP inhibitor predictive biomarker in high-grade serous ovarian cancer. This is an ASCO Meeting Abstract from the 2025 ASCO ...